31 – 40 of 53
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Pharmacoepigenetics in type 2 diabetes : is it clinically relevant?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study
- Contribution to journal › Article
-
Mark
An Algorithm for Strategic Continuation or Restriction of Asthma Medication Prior to Exercise Challenge Testing in Childhood Exercise Induced Bronchoconstriction
- Contribution to journal › Article
-
Mark
Application of precision medicine in clinical routine in haematology—Challenges and opportunities
- Contribution to journal › Scientific review
-
Mark
Implementing precision medicine in a regionally organized healthcare system in Sweden
- Contribution to journal › Letter
-
Mark
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia : Results from the HEAT-AML trial
- Contribution to journal › Article
- 2021
-
Mark
Technological readiness and implementation of genomic-driven precision medicine for complex diseases
- Contribution to journal › Scientific review
-
Mark
Network pharmacology of triptolide in cancer cells : implications for transcription factor binding
- Contribution to journal › Article
-
Mark
Genetically targeted clinical trials in parkinson’s disease : Learning from the successes made in oncology
- Contribution to journal › Scientific review
-
Mark
Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting
- Contribution to journal › Article
